| Type 2 Diabetes Mellitus |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.9 |
| Coronary Artery Disease (CAD) |
0 |
0.85 |
| Heart Failure (HF) |
0 |
0.74 |
| Hypertension |
0 |
0.54 |
| Cardiovascular disease |
0 |
0.5 |
| GLP-1 Receptor Agonist |
0 |
0.5 |
| Heart |
0 |
0.42 |
| Cardiovascular Imaging |
0 |
0.33 |
| Clinical Guidelines |
0 |
0.99 |
| Receptors |
0 |
0.31 |
| SGLT2 Inhibitor |
0 |
0.31 |
| Chronic Kidney Disease |
0 |
0.25 |
| Renal Disease |
0 |
0.25 |
| Renal Failure |
0 |
0.25 |
| Kidney |
0 |
0.23 |
| Ejection Fraction |
0 |
0.18 |
| Europe |
0 |
0.15 |
| Blood |
0 |
0.08 |
| Myocardial Infarction (MI) History |
0 |
0.06 |